NCT01337934View on ClinicalTrials.gov

Lactated Ringer Versus Albumin in Early Sepsis Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2017

Conditions
Septic ShockSevere Sepsis
Interventions
DRUG

Lactated Ringer

Lactated Ringer

DRUG

Albumin

Albumin 4%

Trial Locations (1)

01246000

Cancer Institute of Sao Paulo, School of Medicine, University of Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT01337934 - Lactated Ringer Versus Albumin in Early Sepsis Therapy | Biotech Hunter | Biotech Hunter